David Green - May 12, 2022 Form 4 Insider Report for Biostage, Inc. (BSTG)

Role
Interim CEO, Director
Signature
/s/ Chad Porter, by power of attorney
Stock symbol
BSTG
Transactions as of
May 12, 2022
Transactions value $
$375,002
Form type
4
Date filed
5/23/2022, 02:45 PM
Previous filing
Nov 30, 2021
Next filing
Jan 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSTG Common Stock Purchase $375K +63.3K +66.32% $5.92 159K May 12, 2022 Direct F1
holding BSTG Common Stock 16.5K May 12, 2022 2018 Biostage GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSTG Warrants (right to buy) Purchase +31.7K 31.7K May 12, 2022 Common Stock 31.7K $8.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 12, 2022, the Issuer and the Reporting Person entered into 2 securities purchase agreements (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 63,345 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 31,673 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreements was $375,000.

Remarks:

This form has been signed under power of attorney.